H.R. 8931 — Introduced in House

I 117th CONGRESS 2d Session H. R. 8931 IN THE HOUSE OF REPRESENTATIVES September 21, 2022Mr. Carter of Georgia (for himself and Ms. Ross) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to require the Attorney General to remove a drug from scheduling within 180 days of a certain date pursuant to the recommendation of the Secretary of Health and Human Services, and for other purposes. 1. Short title This Act may be cited as the Improving Access to Safe Medicines Act of 2022. 2. Expedited removal of a controlled substance from scheduling at the recommendation of the Secretary of Health and Human Services Section 201(j) of the Controlled Substances Act (21 U.S.C. 811(j)) is amended— (1) in paragraph (1)— (A) by striking the date described in paragraph (2) and inserting the date described in paragraph (3); and (B) by striking the procedures described in paragraph (3) and inserting the procedures described in paragraph (4); (2) by redesignating paragraphs (2) and (3) as paragraphs (3) and (4), respectively; and (3) by inserting after paragraph (1) the following: (2) If the Secretary of Health and Human Services recommends that the Attorney General remove any drug from the schedules under this title in accordance with this section and section 202, and the Attorney General determines there is no other legal basis to control the drug under this title, the Attorney General shall, not later than 180 days after the date described in paragraph (3), issue a proposed rule to remove the drug from the schedules in accordance with the procedures set forth in subsection (a). .